The Orphan Drug Disconnect
Decades after Congress passed the Orphan Drug Act, only about 10 percent of patients with rare diseases actually receive treatment with orphan drugs, a new report finds.
Tag: Cost Sharing|Cystic Fibrosis|Neurological|Prior Authorization|Rare Disease
